Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alnylam Pharmaceuticals (NQ: ALNY ) 153.86 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4 Open 153.86 Bid (Size) 151.00 (1) Ask (Size) 199.19 (1) Prev. Close 153.86 Today's Range 153.86 - 153.86 52wk Range 141.97 - 218.88 Shares Outstanding 118,847,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today June 14, 2024 Via Benzinga $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today June 13, 2024 Via Benzinga Performance YTD -21.07% -21.07% 1 Month +2.41% +2.41% 3 Month +3.97% +3.97% 6 Month -14.07% -14.07% 1 Year -23.68% -23.68% More News Read More Behind the Scenes of Alnylam Pharmaceuticals's Latest Options Trends June 12, 2024 Via Benzinga June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge June 05, 2024 Via InvestorPlace (ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest May 17, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session May 09, 2024 Via Benzinga How Is The Market Feeling About Alnylam Pharmaceuticals? April 19, 2024 Via Benzinga Alnylam Issues 2023 Corporate Responsibility Report May 07, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire ALNY Stock Earnings: Alnylam Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity May 02, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results April 18, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session April 09, 2024 Via Benzinga Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data April 08, 2024 Via Benzinga Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension April 07, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today April 02, 2024 Via Benzinga Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback March 28, 2024 Via Investor's Business Daily Exposures Product Safety 3 Biotech Stocks to Buy on the Dip: March 2024 March 27, 2024 Via InvestorPlace Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session March 20, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years March 18, 2024 Via Benzinga Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio March 13, 2024 Via InvestorPlace Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease March 13, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates March 09, 2024 Via Talk Markets Exposures Product Safety Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges March 05, 2024 Via Benzinga Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives March 05, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session February 29, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
